In this study, we report the ability of anterior segment optical coherence tomography (AS OCT) in imaging the sub-Tenon space and its clinical application. High-speed AS OCT (Carl Zeiss Meditec, Dublin, Calif., USA) was used to visualize the sub-Tenon space during sub-Tenon injection. The sub-Tenon spaces, Tenon thickness, conjunctiva-Tenon thickness, injecting cannula position in relation to the sub-Tenon space and drug localization/distribution in the sub-Tenon space were analyzed. The sub-Tenon spaces of 12 of 11 patients were visualized with OCT during sub-Tenon injection up to 10-13 mm from the limbus. The mean conjunctiva-Tenon and Tenon thickness were 0.38 ± 0.08 and 0.21 ± 0.07 mm, respectively. The drug was tracked as bright white fluid. There was no conjunctival chemosis, subconjunctival drug or scleral perforation. Anterior segment OCT can be used for imaging the sub-Tenon space, especially during depot injections for confirmation of drug localization.

Cardillo JA, Melo LA, Costa RA, Skaf M, Belfort R Jr, Souza-Filho AA, Farah ME, Kuppermann BD: Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2005;112:1557-1563.
Helm CJ, Holland GN: The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64.
Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR: A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology 1997;104:2003-2008.
Venkatesh P, Garg SP, Verma L, Lakshmaiah NC, Tewari HK: Posterior subtenon injection of corticosteroids using polytetrafluoroethylene (PTFE) intravenous cannula. Clin Experiment Ophthalmol 2002;30:55-57.
Venkatesh P, Kumar CS, Abbas Z, Garg S: Comparison of the efficacy and safety of different methods of posterior subtenon injection. Ocul Immunol Inflamm 2008;16:217-223.
Lafranco Dafflon M, Tran VT, Guex-Crosier Y, Herbort CP: Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 1999;237:289-295.
Bakri SJ, Singh AD, Lowder CY, Chalita MR, Li Y, Izatt JA, Rollins AM, Huang D: Imaging of iris lesions with high-speed optical coherence tomography. Ophthalmic Surg Lasers Imaging 2007;38:27-34.
Kumar DA, Agarwal A, Prakash G, Jacob S, Saravanan Y, Agarwal A: Evaluation of intraocular lens tilt with anterior segment optical coherence tomography. Am J Ophthalmol 2011;151:406-412.
Francoz M, Karamoko I, Baudouin C, Labbé A. Ocular surface epithelial thickness evaluation with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:9116-9123.
Winder S, Walker SB, Atta HR: Ultrasonic localization of anesthetic fluid in sub-Tenon's, peribulbar, and retrobulbar techniques. J Cataract Refract Surg 1999;25:56-59.
Niemi-Murola L, Krootila K, Kivisaari R, Kangasmäki A, Kivisaari L, Maunuksela EL: Localization of local anesthetic solution by magnetic resonance imaging. Ophthalmology 2004;111:342-347.
Trivedi D, Denniston AK, Murray PI: Safety profile of anterior chamber paracentesis performed at the slit lamp. Clin Experiment Ophthalmol 2011;39:725-728.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.